POLISENO, LAURA
 Distribuzione geografica
Continente #
AS - Asia 1.381
NA - Nord America 1.116
EU - Europa 479
SA - Sud America 207
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 37
Totale 3.408
Nazione #
US - Stati Uniti d'America 1.058
SG - Singapore 534
CN - Cina 293
HK - Hong Kong 160
VN - Vietnam 156
BR - Brasile 154
IT - Italia 145
NL - Olanda 97
FR - Francia 70
JP - Giappone 57
KR - Corea 48
GB - Regno Unito 37
BD - Bangladesh 34
CA - Canada 31
IN - India 28
DE - Germania 27
FI - Finlandia 27
AR - Argentina 17
PL - Polonia 16
CO - Colombia 11
EC - Ecuador 11
TR - Turchia 11
ES - Italia 9
ZA - Sudafrica 8
IL - Israele 7
IQ - Iraq 7
MX - Messico 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
IE - Irlanda 5
PH - Filippine 5
RU - Federazione Russa 5
SE - Svezia 5
UA - Ucraina 5
ID - Indonesia 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
PK - Pakistan 4
PY - Paraguay 4
BB - Barbados 3
BG - Bulgaria 3
EE - Estonia 3
EG - Egitto 3
KZ - Kazakistan 3
ML - Mali 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BE - Belgio 2
CL - Cile 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KH - Cambogia 2
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GN - Guinea 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LR - Liberia 1
MD - Moldavia 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SN - Senegal 1
Totale 3.220
Città #
Singapore 351
Santa Clara 197
San Jose 192
Hong Kong 159
Ashburn 119
Hefei 109
Los Angeles 70
Beijing 69
Ho Chi Minh City 61
Seoul 48
Tokyo 47
Lauterbourg 42
Hanoi 36
Amsterdam 15
Lappeenranta 14
Warsaw 14
Helsinki 13
Pisa 13
São Paulo 13
Da Nang 12
Frankfurt am Main 12
Dallas 11
New York 11
Milan 10
Rome 10
Montreal 9
Phoenix 9
Atlanta 8
Cascina 8
Council Bluffs 8
Düsseldorf 8
Houston 8
Portsmouth 8
Brooklyn 7
Buffalo 7
Chennai 7
Guangzhou 7
Minamishinagawa 7
Orem 7
Paris 7
Brasília 6
Haiphong 6
Jacksonville 6
London 6
Queens 6
Tashkent 6
Toronto 6
Chicago 5
Denver 5
Dublin 5
Elk Grove Village 5
Florence 5
Guayaquil 5
Indianapolis 5
Naples 5
Newark 5
Stockholm 5
Bengaluru 4
Biên Hòa 4
Charlotte 4
Jeddah 4
Miami 4
Rio de Janeiro 4
The Bronx 4
Ankara 3
Bamako 3
Bangkok 3
Bogotá 3
Boston 3
Bridgetown 3
Buenos Aires 3
Cincinnati 3
City of London 3
Contagem 3
Dhaka 3
Guarulhos 3
Jundiaí 3
Kyiv 3
Lima 3
Lissone 3
Manchester 3
Mesa 3
Mexico City 3
Mumbai 3
Nairobi 3
Nashville 3
Nha Trang 3
Philadelphia 3
Providence 3
Quito 3
San Giuseppe Vesuviano 3
Santa Maria 3
Turin 3
Vicenza 3
Yerres 3
Abbeville 2
Acalanes Ridge 2
Amman 2
Aracaju 2
Asunción 2
Totale 1.986
Nome #
p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells 98
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 96
A eutherian-specific microRNA controls the translation of Satb2 in a model of cortical differentiation 95
PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation 94
A Network of MicroRNAs and mRNAs Involved in Melanosome Maturation and Trafficking Defines the Lower Response of Pigmentable Melanoma Cells to Targeted Therapy 88
High-Throughput Identification of miRNA-Target Interactions in Melanoma Using miR-CATCHv2.0 84
Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA 81
Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma 75
GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma 73
Enhancing the Anticancer Activity of Attenuated Listeria monocytogenes by Cell Wall Functionalization with "Clickable" Doxorubicin 68
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response 67
Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model 67
Context-dependent miR-204 and miR-211 differentially affect the biological properties of amelanotic and melanotic melanoma cells 67
Development of a yeast-based system to identify new hBRAFV600E functional interactors 64
Editorial: Role of pigmentation in melanoma 64
Coding, or non-coding, that is the question 63
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 62
Inducible modulation of miR-204 levels in a zebrafish melanoma model 61
Identification of BRAF 3'UTR Isoforms in Melanoma 61
PTENP1 is a ceRNA for PTEN: it's CRISPR clear 59
CRISPR/Cas Technologies Applied to Pseudogenes 59
Biosafety and Biokinetics of Noble Metals: The Impact of Their Chemical Nature 59
Inibizione dell'espressione di BCL2 in cellule MCF7 mediante short interfering RNA 58
Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System 57
Efficacy of amphipathic oligopeptide to shuttle and release a cis-acting DNA decoy into human cells 57
In Vivo Silencing/Overexpression of lncRNAs by CRISPR/Cas System 55
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib 54
Alkaline Phosphatase-Positive Immortal Mouse Embryo Fibroblasts Are Cells in a Transitional Reprogramming State Induced to Face Environmental Stresses 54
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 54
The Proto-Oncogene LRF Is under Post-Transcriptional Control of miR-20a: Implications for Senescence 54
An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22 54
Biological role of miR-204 and miR-211 in melanoma 52
Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model 51
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O-6 methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide 51
Methods for the Identification of PTEN-Targeting MicroRNAs 50
Modulazione tra fenotipo sintetico e contrattile: un modello in vitro per studiare l'attivazione di cellule muscolari lisce di coronarie 49
Pseudogenes-functions and protocols 49
The landscape of BRAF transcript and protein variants in human cancer 47
The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage 44
Pseudogenes-functions and protocols, second edition 44
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma 43
The non-coding rna journal club: Highlights on recent papers—9 41
The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide 37
The Non-Coding RNA Journal Club: Highlights on Recent Papers—14 36
Role of the oncogenic BRAFV600E in the osmostress response of yeast Saccharomyces cerevisiae 36
The activity of short interfering RNAs can be inferred from the energy profile 35
Long non-coding RNAs in cancer: implications for personalized therapy 34
Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib 33
The Proto-Oncogene LRF is under Post-Transcriptional Control of MiR-20a:Implications of senescence 33
PARP1 in melanoma: Mechanistic insights and implications for basic and clinical research 33
MicroRNAs modulate the angiogenic properties of HUVECs 33
Resting smooth muscle cells as a model for studying vascular cell activation 29
Application of ribozyme strategy to study the sensitivity of breast cancer cells to cytotoxic drugs 29
Bidirectional switch between synthetic and contractile phenotypes: an in vitro model to study the activating of coronary smooth muscle cells 29
The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation 29
microrna 20 regulates the level of the proto-oncogene LRF and activate cellular senescence in mouse embryo fibroblasts 27
Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes 27
Protein expression profiling and phenotype modulation 24
The analysis of dose response curve comes in useful for the assembly of multi-siRNAs expressing cassettes 20
Identification of active siRNAs against IGF-IR of porcine coronary smooth muscle cells in a heterologous cell line 19
miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation 18
RNA-based drugs: From RNA interference to short interfering RNAs 17
Bcl2-negative MCF7 cells overexpress p53: Implications for the cell cycle and sensitivity to cytotoxic drugs 17
The energy profiling of short interfering RNAs is highly predictive of their activity 17
PTEN ceRNA networks in human cancer 17
Bcl2-low-expressing MCF7 cells undergo necrosis rather than apoptosis upon staurosporine treatment 16
Landscape of BRAF transcript variants in human cancer 16
Pseudogenes: Newly discovered players in human cancer 15
Pseudogenes in human cancer 14
Unveiling a Novel Molecular Interaction and Pro-Metastatic Signaling Cascades Driven by KRIT1 13
null 8
null 7
null 7
null 6
null 5
null 5
null 5
null 5
null 5
null 4
null 4
null 4
null 4
null 4
null 3
null 3
null 3
Totale 3.408
Categoria #
all - tutte 11.682
article - articoli 9.773
book - libri 374
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 800
Totale 22.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 0 0 0 0 0 0 1 0 12 2
2024/20251.219 8 2 69 43 322 56 18 57 53 124 257 210
2025/20261.825 94 130 130 272 299 126 291 69 100 179 74 61
2026/2027349 74 57 218 0 0 0 0 0 0 0 0 0
Totale 3.408